Literature DB >> 19588387

Non-steroidal anti-inflammatory drugs for the common cold.

Soo Young Kim1, Yoon-Jung Chang, Hye Min Cho, Ye-Won Hwang, Yoo Sun Moon.   

Abstract

BACKGROUND: Although non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of pain and fever associated with the common cold, there is no systematic review to assess the effects of NSAIDs in patients with the common cold.
OBJECTIVES: To determine the effects of NSAIDs versus placebo and other treatments on the signs and symptoms of the common cold. To determine any adverse effects of NSAIDs in patients treated with NSAIDs for the common cold. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 1) which includes the Acute Respiratory Infections (ARI) Group's Specialized Register; MEDLINE (January 1966 to March 2009); EMBASE (January 1980 to March 2009); CINAHL (January 1982 to March 2009); ProQuest Digital Dissertations (January 1938 to March 2009); KoreaMed (January 1958 to March 2009) and KMbase (January 1949 to March 2009). SELECTION CRITERIA: Randomized controlled trials (RCTs) studying treatment of the common cold with NSAIDs in adults or children. DATA COLLECTION AND ANALYSIS: Four review authors extracted data (SYK, YSM, YJC, YWH). We subdivided trials into placebo-controlled RCTs and NSAIDs versus NSAIDs RCTs. We extracted and summarized data on global efficacies: analgesic effects such as reduction of headache and myalgia; non-analgesic effects such as reduction of nasal symptoms, cough, sputum and sneezing; and side effects. MAIN
RESULTS: This review includes nine RCTs, describing 37 comparisons: six were NSAIDs versus placebo, and three were NSAIDs versus NSAIDs. A total of 1064 patients with the common cold were included. In a pooled analysis, NSAIDs did not significantly reduce the total symptom score, or duration of colds.However, for outcomes related to the analgesic effects of NSAIDs (headache, ear pain, and muscle and joint pain) NSAIDs produced significant benefits, and malaise showed a borderline benefit, although throat irritation was not improved. Chills showed mixed results. For respiratory symptoms, cough and nasal discharge scores were not improved, but the sneezing score significantly improved. We found no evidence of increased frequency of adverse effects in the NSAID treatment groups. AUTHORS'
CONCLUSIONS: The authors recommend NSAIDs for relieving discomfort or pain caused by the common cold. Further research is needed to investigate the effect of NSAIDs in relieving respiratory symptoms such as cough and nasal discharge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588387     DOI: 10.1002/14651858.CD006362.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  15 in total

1.  Treating cough and cold: Guidance for caregivers of children and youth.

Authors:  Ran D Goldman
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

Review 2.  Prevention and treatment of the common cold: making sense of the evidence.

Authors:  G Michael Allan; Bruce Arroll
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

3.  Non-steroidal Anti-inflammatory Drugs (NSAIDs) Use in Primary Health Care Centers in A'Seeb, Muscat: A Clinical Audit.

Authors:  Asma Al-Shidhani; Naama Al-Rawahi; Abdulhakeem Al-Rawahi
Journal:  Oman Med J       Date:  2015-09

4.  Reducing uncertainty in managing respiratory tract infections in primary care.

Authors:  Naomi Stanton; Nick A Francis; Chris C Butler
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

Review 5.  Complementary and alternative medicine for prevention and treatment of the common cold.

Authors:  Richard Nahas; Agneta Balla
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

Review 6.  Intranasal ipratropium bromide for the common cold.

Authors:  Zaina H AlBalawi; Sahar S Othman; Khalid Alfaleh
Journal:  Cochrane Database Syst Rev       Date:  2013-06-19

7.  Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole.

Authors:  Shin-Ichi Akanuma; Yasuo Uchida; Sumio Ohtsuki; Masanori Tachikawa; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-10-21

8.  A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers.

Authors:  Federico Lavorini; Elisa Chellini; Margherita Innocenti; Giacomo Campi; Colin Gerard Egan; Selene Mogavero; Giovanni A Fontana
Journal:  Cough       Date:  2014-12-24

9.  Public health and budget impact of probiotics on common respiratory tract infections: a modelling study.

Authors:  Irene Lenoir-Wijnkoop; Laetitia Gerlier; Jean-Louis Bresson; Claude Le Pen; Gilles Berdeaux
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies.

Authors:  Il-Kwon Choi; Hyun-Keun Lee; Young-Jung Ji; In-Hong Hwang; Soo Young Kim
Journal:  Korean J Fam Med       Date:  2013-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.